Blood test could help track Alzheimer’s disease progression and severity

Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer’s disease, particularly in women.

AAO 2023: Phase II ALTITUDE study provides promising results for ABBV-RGX-314 – Pharmaceutical Technology

Currently, less than 1% of diabetic retinopathy (DR) patients are getting treatment early and in the next five years, the population of DR patients is

November 9, 2023

Leveragen and Moderna enter partnership to advance therapeutics

Leveragen will use the platform to create several binding modules against therapeutic targets chosen by Moderna. Credit: MIND AND I / Shutterstock. Leveragen and Moderna

July 31, 2024

CDC: Deadly Vibrio Bacteria Killed Five People in Three States Last Summer

Over just 2 summer months last year, three Eastern states reported 11 cases of severe Vibrio vulnificus infections, of which five resulted in death, CDC

February 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.